Joe Brusuelas of RCM: 'No vaccine, no recovery'

Joseph Brusuelas, chief economist at RCM, says the risks of a sub-par recovery are rising as uncertainty over the outcome of the coronavirus pandemic drags on, and while he still believes that there will be a swoosh-shaped 'elongated and frustratingly slow recovery,' he says even that can't happen until the market knows how the pandemic will be resolved. In the Market Call, Barry James of the James Advantage Funds says investors need to be looking at securities in different time periods -- BC and AD, for 'before coronavirus' and 'after disease' -- and notes that the pandemic has injected a little more subjectivity into stock research right now. Also, Chuck answers a question from the audience, and Tom Lydon of ETFTrends.com makes a new fund based on a market niche that is in the news the 'ETF of the Week.'